Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,515,409 shares of the company's stock after selling 160,350 shares during the period. Vanguard Group Inc. owned approximately 9.88% of Azenta worth $225,770,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. State Street Corp grew its stake in shares of Azenta by 0.4% during the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company's stock worth $81,718,000 after purchasing an additional 6,398 shares during the period. Conestoga Capital Advisors LLC boosted its holdings in Azenta by 65.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after buying an additional 621,830 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Azenta by 1.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock valued at $65,922,000 after buying an additional 18,529 shares in the last quarter. Royce & Associates LP increased its holdings in Azenta by 2.4% in the fourth quarter. Royce & Associates LP now owns 758,068 shares of the company's stock valued at $37,903,000 after buying an additional 18,091 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Azenta by 11.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 461,603 shares of the company's stock valued at $23,080,000 after acquiring an additional 48,064 shares during the period. Hedge funds and other institutional investors own 99.08% of the company's stock.

Remove Ads

Azenta Trading Down 10.4 %

Shares of NASDAQ AZTA traded down $3.08 during trading on Thursday, reaching $26.53. The company had a trading volume of 1,128,013 shares, compared to its average volume of 627,449. Azenta, Inc. has a twelve month low of $25.36 and a twelve month high of $63.58. The stock has a 50-day moving average price of $39.93 and a two-hundred day moving average price of $44.89. The stock has a market capitalization of $1.21 billion, a PE ratio of -8.90 and a beta of 1.66.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, sell-side analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analyst Weigh In

AZTA has been the subject of several research analyst reports. Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Stephens restated an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Evercore ISI boosted their price objective on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Finally, TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.